SCHEMBL21477549

SCHEMBL21477549

CCc1nnc2c(n1)C=CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21477571 0.68 — —
SCHEMBL14572406 0.57 MAPT (0.42) —
SCHEMBL14050809 0.56 — —
SCHEMBL17581115 0.56 — —
SCHEMBL10271455 0.56 KDM4E (0.42) —
SCHEMBL13811976 0.54 — —
SCHEMBL12260190 0.54 — —
SCHEMBL2614743 0.53 HRH4 (0.33) —
SCHEMBL4235547 0.53 — —
SCHEMBL8380266 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3553056-A1 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen Targetrx, Inc. (CN) 2019-10-16 — — EP disclosed
Send feedback